Owen B. Wallace

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Markus Warmuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Owen B. Wallace:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Chief Scientific Officer Common Stock 5,266 $100,054 $19.00 02 Jan 2024 Direct
Monte Rosa Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 119,000 02 Jan 2024 Direct

Insider Reports Filed by Owen B. Wallace

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GLUE Monte Rosa Therapeutics, Inc. 02 Jan 2024 1 $0 4 Chief Scientific Officer 04 Jan 2024, 16:15
GLUE Monte Rosa Therapeutics, Inc. 03 Jan 2023 1 $0 4 Chief Scientific Officer 04 Jan 2023, 15:31
GLUE Monte Rosa Therapeutics, Inc. 01 Mar 2022 1 $0 4 Chief Scientific Officer 02 Mar 2022, 17:32
GLUE Monte Rosa Therapeutics, Inc. 23 Jun 2021 0 $0 3 Chief Scientific Officer 23 Jun 2021, 20:35
GLUE Monte Rosa Therapeutics, Inc. 12 Apr 2021 2 $0 4 Chief Scientific Officer 25 Jun 2021, 17:00